PDB91 An MCDA approach in the evaluation of new technologies for familial hypercholesterolemia treatment

Página do item simplificado
dc.contributor.authorNascimento, A
dc.contributor.authorMorais, QCD
dc.contributor.authorRey, HCVR
dc.contributor.authorAssad, M
dc.contributor.authorTura, BR
dc.contributor.authorSantos Jr, B
dc.contributor.authorSantos, MS
dc.date.accessioned2022-09-28T14:43:47Z
dc.date.available2022-09-28T14:43:47Z
dc.date.issued2019
dc.description.abstractTo rank medicines to be prioritizing in the management of familial hypercholesterolemia (FH) using the multicriteria decision analysis (MCDA) method MACBETH. FH is a hereditary rare disease associated with some gene mutation responsible for regulate the lipid metabolism and cause early cardiovascular eventsen
dc.identifier.citationNascimento A, Morais QCD, Rey HCVR, Assad M, Tura BR, Santos Jr B, Santos MS. An MCDA approach in the evaluation of new technologies for familial hypercholesterolemia treatment. Value in Health. 2019;22(suppl.3):S589.
dc.identifier.doiDOI: 10.1016/j.jval.2019.09.973
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/318
dc.language.isoen
dc.publisherValue in Health
dc.subjectMACBETHen
dc.subjectFamilial hypercholesterolemiaen
dc.titlePDB91 An MCDA approach in the evaluation of new technologies for familial hypercholesterolemia treatmenten
dc.typePresentationen
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Produção técnica_Nascimento, A et al_2019.pdf
Tamanho:
380.11 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar
Coleções
Produção Técnica
Produção Discente
Produção em Conjunto com Discente